June 19, 2018 / 5:18 AM / 5 months ago

Roche to pay $2.4 bln to buy rest of Foundation Medicine

ZURICH, June 19 (Reuters) - Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI), valuing the U.S. genomic profiling group at $5.3 billion, the partners said on Tuesday.

The deal, backed by the boards of both companies, is set to close in the second half on this year, they said in a statement. The offer price represented a premium of 29 percent to FMI's closing price on Monday. (Reporting by Michael Shields, editing by John Revill)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below